Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Core Laboratories N.V. (CLB : NYSE)

• Company Description    Core Laboratories N.V. is a leading provider of proprietary and patented Reservoir Description and Production Enhancement services. Core Laboratories' reservoir optimization technologies are used to increase total recovery from existing fields. Core Laboratories' services enable clients to optimize reservoir performance and maximize hydrocarbon recovery from their producing fields. Core Laboratories has taken extensive measures to ensure the services and data provided by all of worldwide companies are of the highest quality and integrity. Core Laboratories' commitment to applying and developing new technologies to optimize reservoir performance is unsurpassed in the oilfield service industry. This commitment to technology and to your bottom line makes Core Laboratories, The Reservoir Optimization Company. Number of Employees: 3,700

• Price / Volume Information    Yesterday's Closing Price: $24.47 Daily Weekly Monthly 20 Day Moving Average: 510,225 shares Shares Outstanding: 46.31 (millions) Market Capitalization: $1,133.15 (millions) Beta: 2.71 52 Week High: $49.87 52 Week Low: $21.08 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -24.08% -17.14% 12 Week -6.50% -1.56% Year To Date 9.68% 27.85%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL VAN HEUVEN GOEDHARTLAAN 7 B 1181 LE - AMSTELVEEN,P7 1077 XX NLD ph: 31-20-420-3191 fax: - investor.relations@corelab.com http://www.corelab.com

• General Corporate Information    Officers Lawrence Bruno - Chief Executive Officer; Chairman;President Christopher S. Hill - Senior Vice President and Chief Financial Officer Kevin G. Daniels - Vice President; Treasurer Gregory B. Barnett - Director Martha Z. Carnes - Director Peer Information Core Laboratories N.V. (BJS) Core Laboratories N.V. (CXIPY) Core Laboratories N.V. (ALY) Core Laboratories N.V. (HLX) Core Laboratories N.V. (CNCJQ) Core Laboratories N.V. (FGHLQ) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: OIL-FIELD SVCS Sector: Oils/Energy CUSIP: N22717107 SIC: 1389 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: 07/27/22 Share - Related Items Shares Outstanding: 46.31 Most Recent Split Date: 7.00 (2.00:1) Beta: 2.71 Market Capitalization: $1,133.15 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.16% Current Fiscal Quarter EPS Consensus Estimate: $0.14 Indicated Annual Dividend: $0.04 Current Fiscal Year EPS Consensus Estimate: $0.68 Payout Ratio: 0.06 Number of Estimates in the Fiscal Year Consensus: 5.00 Change In Payout Ratio: -0.59 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: 05/06/2022 - $0.01 Next EPS Report Date: 07/27/22

• Fundamental Ratios P/E Current FY Estimate: 35.88 Trailing 12 Months: 38.23 PEG Ratio: - Price Ratios Price/Book: 6.81 Price/Cash Flow: 21.87 Price / Sales: 2.37 EPS Growth vs. Year Ago Period: -46.67% vs. Previous Quarter: -60.00% Sales Growth vs. Year Ago Period: 6.38% vs. Previous Quarter: -7.86% ROE 03/31/22 - 18.28 12/31/21 - 21.03 09/30/21 - 23.49 ROA 03/31/22 - 5.00 12/31/21 - 5.57 09/30/21 - 5.40 Current Ratio 03/31/22 - 2.03 12/31/21 - 2.08 09/30/21 - 2.01 Quick Ratio 03/31/22 - 1.54 12/31/21 - 1.58 09/30/21 - 1.54 Operating Margin 03/31/22 - 6.16 12/31/21 - 6.96 09/30/21 - 6.87 Net Margin 03/31/22 - 2.04 12/31/21 - 4.20 09/30/21 - 6.66 Pre-Tax Margin 03/31/22 - 4.78 12/31/21 - 7.68 09/30/21 - 9.80 Book Value 03/31/22 - 3.59 12/31/21 - 3.48 09/30/21 - 3.48 Inventory Turnover 03/31/22 - 8.62 12/31/21 - 8.78 09/30/21 - 8.96 Debt-to-Equity 03/31/22 - 1.14 12/31/21 - 1.17 09/30/21 - 1.17 Debt-to-Capital 03/31/22 - 53.29 12/31/21 - 53.95 09/30/21 - 53.93

Powered by Zacks Investment Research ©